Filing Details

Accession Number:
0001610717-25-000145
Form Type:
4
Zero Holdings:
No
Publication Time:
2025-05-28 17:12:50
Reporting Period:
2025-05-23
Filing Date:
2025-05-28
Accepted Time:
2025-05-28 17:12:50
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1512762 Coherus Biosciences Inc. CHRS () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1459154 Mats Wahlstrom C/O Coherus Biosciences, Inc.
333 Twin Dolphin Drive, Suite 600
Redwood City CA 94065
No No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2025-05-23 99,988 $0.74 0 No 4 S Indirect Leonard Capital, LLC
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Indirect Leonard Capital, LLC
Footnotes
  1. The reported sale transactions were effected for tax planning purposes.
  2. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $0.7362 to $0.7448, exclusive of any fees, commissions or other expenses. The Reporting Person undertakes to provide to Coherus BioSciences, Inc., any security holder of Coherus BioSciences, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (2) to this Form 4.
  3. The Reporting Person and his spouse are the members of Leonard Capital, LLC and therefore the Reporting Person may be deemed to have voting and dispositive power of shares held by Leonard Capital, LLC.